Welcome

Crouching black cat with gold eyes.

Share Your Story #zorbiumlawsuit Update 1/5/25

Dear Zorbium Families,

I want to be transparent – I have not yet read all of your individual stories as the emotional weight of each loss is significant. Having experienced a similar loss, I understand how difficult it can be to revisit these experiences and I find myself moved to tears each time.

Through Freedom of Information Law (FOIL) requests and other channels, here are the documented facts:

  • The FDA responded in December 2024, confirming they have received reports of over 230 cat deaths and nearly 3,000 adverse events since Zorbium’s approval in January 2022.  As of 1/12/2025 266 cats perished, and adverse events of course, have also risen to over 3,000.
  • The DEA responded in January 2025, denying access to buprenorphine supply data under FOIA exemptions (b)(4) and (b)(7)(E).
  • Responses from state agencies have varied, with some providing more detailed information than others.

Public records also indicate that Elanco has filed patent applications in multiple countries. These applications are publicly accessible through patent office databases.

Current actions include:

  • Submitted inquiries to FDA’s Center for Veterinary Medicine
  • Filed FOIA/FOIL requests with multiple agencies
  • Documenting reported cases
  • Connecting with legal professionals
  • Engaged with journalists investigating this issue

Each submission helps build understanding of this issue. Every report contributes to the documented record.

For those seeking to report adverse events, please report both to Elanco AND the FDA so we can be sure that the stories get heard. Your voices matter, and your family cats matter. Together, our stories are creating a documented record that cannot be ignored.

You are not alone in this fight. This is now a global concern, and we are working to prevent other families worldwide from experiencing similar tragedies.

Thank you for your strength and courage in sharing your stories.